Gabapentin Capsule
Product Images NDC 55154-8194

8 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 55154-8194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Equation)

Gabapentin-equation (Equation)
A formula for calculating creatinine clearance (CLCr) based on age, weight, serum creatinine, and a factor for female patients. This panel provides a mathematical expression used in clinical contexts but does not contain specific drug information.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of gabapentin, showing a cyclohexane ring bonded to groups containing amino (CH2NH2) and carboxyl (CH2CO2H) functional groups.*
FDA Label Image

Gabapentin-fig1 (Figure1)

Gabapentin-fig1 (Figure1)
A line graph depicting mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis shows weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis ranges from 0 to 10 representing mean pain scores. Gabapentin group shows a downward trend in pain scores, while placebo remains relatively stable.*
FDA Label Image

Gabapentin-fig2 (Figure2)

Gabapentin-fig2 (Figure2)
A line graph showing mean pain scores over a 7-week period comparing placebo and two doses of Gabapentin (1800 mg/day and 2400 mg/day). The x-axis represents weeks, with a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis shows pain scores from 0 to 10, illustrating reduced pain scores for both Gabapentin doses compared to placebo.*
FDA Label Image

Gabapentin-fig3 (Figure3)

Gabapentin-fig3 (Figure3)
A bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares response rates for placebo (PBO) and gabapentin (GBP) at different doses across two studies. Study 1 shows 12% for PBO and 29% for GBP 3600 mg. Study 2 shows 14% for PBO, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Significance indicators (** and ***) denote p-values less than 0.01 and 0.001, respectively.*
FDA Label Image

Gabapentin-fig4.jpg (Figure4)

Gabapentin-fig4.jpg (Figure4)
A scatter plot chart showing percentage difference on the y-axis and daily dose in mg on the x-axis for Gabapentin studies. It compares three studies labeled as Study a, Study b, and Study c across doses of approximately 600, 900, 1200, and 1800 mg, with Study a and b showing higher differences at the highest and intermediate doses respectively.*
FDA Label Image

100mg Bag Label (404371e4 9470 D2a0 E063 6394a90acdef 01)

100mg Bag Label (404371e4 9470 D2a0 E063 6394a90acdef 01)
Label for Gabapentin Capsules, USP 100 mg, in a package containing 10 capsules. The label includes storage instructions, dosage reference, and warnings that the unit dose package is not child resistant and intended for institutional use only. It lists the distributor as Cardinal Health and American Health Packaging with addresses in Ohio. The label also directs pharmacists to dispense the medication guide to each patient.*
FDA Label Image

300mg Bag Label (404371e4 9470 D2a0 E063 6394a90acdef 00)

300mg Bag Label (404371e4 9470 D2a0 E063 6394a90acdef 00)
Gabapentin capsules USP 300 mg unit dose package containing 10 capsules. Label includes storage instructions, usage warnings, and distributor information. Rx only, not child resistant, intended for institutional use. Distributed by Cardinal Health and American Health Packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.